文献速递慢病防控与筛查卫生政策与健康促进

1996-2017年按种族划分的处方阿片类与非阿片类镇痛药使用趋势

Trends in Prescription Opioid and Nonopioid Analgesic Use by Race, 1996-2017.
PubMed 文献 · Am J Prev Med · 2021-12-07

研究利用医疗支出面板调查分析1996-2017年无癌症成年平民中按种族划分的处方阿片类使用(POU)与仅非阿片类镇痛药使用(ENA)趋势。基线时非西班牙裔白人POU最高(11.9%)与ENA(11.3%)相当,非西班牙裔黑人和西班牙裔POU较低(9.3%和9.6%)且ENA超过POU。随后各一种族POU增加、ENA减少,白人和黑人POU最终超过ENA而西班牙裔未出现;2016-2017年处方限制后POU在各一种族以相当水平下降。

要点

  • 基线时非西班牙裔白人POU为11.9%,与ENA的11.3%相当。
  • 非西班牙裔黑人和西班牙裔基线POU分别为9.3%和9.6%,均低于白人。
  • 2016-2017年处方限制后,POU在各一种族以相当水平下降。

核心结论

  • 黑人和西班牙裔在阿片类药物首次广泛用于非癌痛时使用阿片类的可能性较低。
  • 随后POU在白人和黑人中取代了ENA。
  • 尽管POU常与白人关联,相当比例的黑人人群也可能面临风险。
  • 西班牙裔POU较低可能对误用有保护作用,但也可能代表治疗不足。

研究设计与样本

  • 研究使用医疗支出面板调查(Medical Expenditure Panel Survey)分析1996年至2017年无癌症成年平民(年龄≥18岁)的镇痛药使用。
  • 分析在2020年12月至2021年4月间进行。
  • 结局将个体分为3个互斥的处方镇痛药使用类别:无处方镇痛药、POU和ENA。

主要发现

  • 在250,596名成人中,基线镇痛药使用随种族-族裔而异:非西班牙裔白人POU最高(11.9%),与ENA(11.3%)一样普遍。
  • 非西班牙裔黑人和西班牙裔基线POU较低(分别为9.3%和9.6%),且ENA超过POU。
  • 随后POU在各一种族-族裔中增加,同时ENA减少,最终在白人和黑人中POU超过ENA,但在西班牙裔中未超过。
  • 尽管黑人的POU在2000年代-2010年代变得与白人一样普遍,但西班牙裔的POU在整个2000年代-2010年代保持低于其他组。
  • 在采用处方限制后,2016-2017年POU在各一种族-族裔中以相当水平下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Identifying racial differences in trends in prescription opioid use (POU) is essential for formulating evidence-based responses to the opioid epidemic. This study analyzes trends in the prevalence of POU and exclusive nonopioid analgesic use (ENA) by race-ethnicity. METHODS: The Medical Expenditure Panel Survey was used to examine analgesic use among civilian adults without cancer (age ≥18 years) between 1996 and 2017. The outcome classified individuals into 3 mutually exclusive categories of prescription analgesic use: no prescription analgesic, POU, and ENA. Analyses were conducted between December 2020 and April 2021. RESULTS: Among 250,596 adults, baseline analgesic usage varied with race-ethnicity, where non-Hispanic Whites had the highest POU (11.9%), and it was as prevalent as ENA (11.3%). Non-Hispanic Blacks and Hispanics had lower POU at baseline (9.3% and 9.6%, respectively), and ENA exceeded POU. Subsequently, POU increased across race-ethnicity with concomitant decreases in ENA, eventually eclipsing ENA in Whites and Blacks but not among Hispanics. Although POU among Blacks became as prevalent as it was among Whites in the 2000s-2010s, POU among Hispanics remained lower than the other groups throughout the 2000s-2010s. After the adoption of prescribing limits, POU declined across race-ethnicity by comparable levels in 2016-2017. CONCLUSIONS: Blacks and Hispanics were less likely to use opioids when they first became widely available for noncancer pain. Subsequently, POU displaced ENA among Whites and Blacks. Although POU is often associated with Whites, a significant proportion of the Black population may also be at risk. Finally, although lower POU among Hispanics may be protective of misuse, it could represent undertreatment.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Cho G, Chang VW. Trends in Prescription Opioid and Nonopioid Analgesic Use by Race, 1996-2017. Am J Prev Med. 2021. PMID: 35190102. doi:10.1016/j.amepre.2021.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。